Literature DB >> 32495263

The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair.

Parinaz Zivarpour1, Željko Reiner2, Jamal Hallajzadeh3, Liaosadat Mirsafaei4, Zatollah Asemi5.   

Abstract

Cardiac fibrosis is one of the most common pathological conditions caused by different heart diseases, including myocardial infarction and diabetic cardiomyopathy. Cardiovascular disease is one of the major causes of mortality worldwide. Cardiac fibrosis is caused by different processes, including inflammatory reactions and oxidative stress. The process of fibrosis begins by changing the balance between production and destruction of extracellular matrix components and stimulating the proliferation and differentiation of cardiac fibroblasts. Many studies have focused on finding drugs with less adverse effects for the treatment of cardiovascular disease. Some studies show that nutraceuticals are effective in preventing and treating diseases, including cardiovascular disease, and that they can reduce the risk. However, big clinical studies to prove the therapeutic properties of all these substances and their adverse effects are lacking so far. Therefore, in this review, we tried to summarize the knowledge on pathways and mechanisms of several nutraceuticals which have shown their usefulness in the prevention of cardiac fibrosis.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiac fibrosis; Cardiovascular disease; Inflammatory markers; Nutraceuticals; Oxidative stress

Mesh:

Year:  2022        PMID: 32495263     DOI: 10.1007/s10741-020-09980-6

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  152 in total

Review 1.  Cardiac fibrosis: potential therapeutic targets.

Authors:  Shuin Park; Ngoc B Nguyen; Arash Pezhouman; Reza Ardehali
Journal:  Transl Res       Date:  2019-03-09       Impact factor: 7.012

Review 2.  Defining 'nutraceuticals': neither nutritious nor pharmaceutical.

Authors:  Jeffrey K Aronson
Journal:  Br J Clin Pharmacol       Date:  2016-04-25       Impact factor: 4.335

Review 3.  Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel.

Authors:  Arrigo F G Cicero; Alessandro Colletti; Gani Bajraktari; Olivier Descamps; Dragan M Djuric; Marat Ezhov; Zlatko Fras; Niki Katsiki; Michel Langlois; Gustavs Latkovskis; Demosthenes B Panagiotakos; Gyorgy Paragh; Dimitri P Mikhailidis; Olena Mitchenko; Bernhard Paulweber; Daniel Pella; Christos Pitsavos; Željko Reiner; Kausik K Ray; Manfredi Rizzo; Amirhossein Sahebkar; Maria-Corina Serban; Laurence S Sperling; Peter P Toth; Dragos Vinereanu; Michal Vrablík; Nathan D Wong; Maciej Banach
Journal:  Nutr Rev       Date:  2017-09-01       Impact factor: 7.110

4.  Effects of combination of angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist on inflammatory cellular infiltration and myocardial interstitial fibrosis after acute myocardial infarction.

Authors:  C M Yu; G L Tipoe; K Wing-Hon Lai; C P Lau
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

5.  Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action.

Authors:  Hui-Ping Gu; Sen Lin; Ming Xu; Hai-Yi Yu; Xiao-Jun Du; You-Yi Zhang; Gu Yuan; Wei Gao
Journal:  Endocrinology       Date:  2012-06-06       Impact factor: 4.736

Review 6.  Nutraceuticals in Migraine: A Summary of Existing Guidelines for Use.

Authors:  Thilinie Rajapakse; Tamara Pringsheim
Journal:  Headache       Date:  2016-03-07       Impact factor: 5.887

7.  Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.

Authors:  Ramón Querejeta; Begoña López; Arantxa González; Eloy Sánchez; Mariano Larman; José L Martínez Ubago; Javier Díez
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

Review 8.  Extracellular matrix remodeling and cardiac fibrosis.

Authors:  Li Li; Qian Zhao; Wei Kong
Journal:  Matrix Biol       Date:  2018-01-31       Impact factor: 11.583

Review 9.  Nutraceuticals: opening the debate for a regulatory framework.

Authors:  Antonello Santini; Silvia Miriam Cammarata; Giacomo Capone; Angela Ianaro; Gian Carlo Tenore; Luca Pani; Ettore Novellino
Journal:  Br J Clin Pharmacol       Date:  2018-02-14       Impact factor: 4.335

Review 10.  Cardiac fibrosis: new insights into the pathogenesis.

Authors:  Zhen-Guo Ma; Yu-Pei Yuan; Hai-Ming Wu; Xin Zhang; Qi-Zhu Tang
Journal:  Int J Biol Sci       Date:  2018-09-07       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.